Entries by

Compass Pathways IPO Brings $1 Billion Valuation

UK-based Compass Pathways led a groundbreaking IPO last week. Share prices spiked 71 percent to nearly $30 after the initial offering of 7.5 million shares, which launched at $17 each. Current value of the company based on its 34 million shares is estimated at nearly $1 billion. It’s listed on Nasdaq as “CMPS.” The mental […]

Johns Hopkins to Build World’s Largest Registry on Psilocybin Use

The John Hopkins Center for Psychedelic and Consciousness Research (CPCR) will create the world’s largest registry on psilocybin use, the center announced last month. In a partnership with Unlimited Sciences, a psychedelic research nonprofit, CPCR will create the registry by surveying people across the globe about their psilocybin mushroom use. This would mark a shift […]

Why Investors Are Betting On Psychedelics

While they’ve historically brought the risk of long jail sentences, psychedelics are now bringing another long-term scenario: big-time investments. The potential for psychedelics in treating mental disorders such as depression, suicidal thoughts, PTSD, and anxiety, is bringing interest from Wall Street. Dozens of biopharmaceutical companies are exploring investment opportunities to further develop the psychedelic marketplace. […]

Ann Arbor Michigan Decriminalizes Psychedelics

Ann Arbor Michigan, home to Big 10 college football at the University of Michigan, is now about to become another big designation — the city is taking a substantial stance in favor of psychedelic substances. The Ann Arbor City Council voted this week to decriminalize psychedelic substances including ayahuasca, ibogaine, mescaline, peyote, and psilocybin mushrooms, […]

The Psychedelic Medicine Association Launches to Align the Industry

A first of its kind, The Psychedelic Medicine Association (PMA) is set to launch on September 29th. The association aligns medical establishments, patients, and industry leaders in the advancement of psychedelic therapy. “We want physicians and other healthcare providers to feel comfortable discussing psychedelic medicines with their patients, as many of these therapies are significantly […]

New Partnership Will Bring Quick-Dissolve Strips to Psychedelics

Psychedelic drugs could soon have a standardized, and much faster delivery method with the announcement last month that ATAI Life Sciences AG and IntelGenx have entered into an agreement to develop polymeric film technologies. The quick-dissolve film will be used as a delivery mechanism for psychedelic substances. Canada-based IntelGenx already creates quick-dissolving films for widely distributed pharmaceuticals […]

Canadian Manufacturer Licensed to Make Psilocybin

Vancouver-based Mydecine Innovations Group, Inc., has become the first company to earn the license to legally produce and distribute pharmaceutical-grade psilocybin in Canada, the company announced last month. Mydecine, which also has offices in the U.S., derives its psilocybin through a whole mushroom extraction process. “Mydecine’s breakthrough to legally supply naturally-sourced psilocybin within our spore-to-sale™ […]

One Ayahuasca Ceremony Might Reset Mental Health

A single experience with the psychedelic South American brew called ayahuasca may help reduce psychopathology and depression in users for up to six months, a new study finds. The findings, published in the recent issue of the journal Scientific Reports, looked at ayahuasca use in a group of 40 women and men aged 20-65. All were screened for […]

Denver’s ‘Magic’ Mushroom Law: What You Need to Know

Mushrooms are experiencing a renaissance. Or, rather, they’re now prototypes, paving paths as tools for everything from sustainable meat to animal-free leather. Now a few cities are decriminalizing magic mushrooms as psilocybin’s medicinal potential earns a spotlight with prestigious research facilities and medical journals. Denver voted to decriminalize psychedelic mushrooms last year, the first U.S. […]